Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
GoPath Diagnostics United States | 4 | 14 |
|
Hereditary Prostate Cancer Panel QDx Pathology Services, Inc. United States | 1 | 16 |
|
QDx Pathology Services, Inc. United States | 15 | 44 |
|
Hereditary Prostate Cancer Panel Clariti Diagnostics Laboratories LLC United States | 1 | 16 |
|
Clariti Diagnostics Laboratories LLC United States | 15 | 44 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
OnkoRisk Hereditary Oncology Management Panel BioReference Health United States | 47 | 17 |
|
OnkoRisk Women's Hereditary Cancer Panel BioReference Health United States | 34 | 18 |
|
OnkoRisk Hereditary Urology Panel BioReference Health United States | 27 | 19 |
|
BioReference Health United States | 4 | 2 |
|
Myriad Genetics, Inc. United States | 1 | 1 |
|
INTEGRATED MEDICAL PROFESSIONALS, PLLC United States | 2 | 10 |
|
Invitae United States | 59 | 16 |
|
Centogene AG - the Rare Disease Company Germany | 11 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 11 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 11 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 58 | 28 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.